TMCnet News
Research and Markets: TSLP Signaling Pathway in Oncology Drug Pipeline Analysis 2015Research and Markets (http://www.researchandmarkets.com/research/5t62t2/tslp_signaling) has announced the addition of the "TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015" report to their offering. Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of biological procedures. TSLP can be secreted by epithelial cells upon pathogen stimulation. TSLP can also activate dendritic cells, CD4+ T cells and CD8+ T cells. TSLP not only activate the JAK/STAT pathway but also induce phosphorylation of other signaling molecules including PI3K/Akt, ERK1/2 and JNKs. Aberrant TSLP signaling is implicated in a number of the development of diseases, includin asthma, atopic dermatitis, eosinophilic eosophagitis and acute lymphoid leukemia. There are today 198 companies plus partners developing 228 TSLP pathway targeting drugs in 1035 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 167 drugs. Tslp Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 172 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 170 out of the 172 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 43 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath. Pipeline Breakdown According to Number of Drugs
Delivery Format: Desktop App plus Online Access to Updates (One Year) For more information visit http://www.researchandmarkets.com/research/5t62t2/tslp_signaling
|
